Literature DB >> 9788532

Distribution of paroxetine in three postmortem cases.

T Vermeulen1.   

Abstract

Paroxetine (Paxil) is a selective serotonin reuptake inhibitor, one of a new class of antidepressants used in the treatment of obsessive-compulsive disorder, panic disorder, and depression. Paroxetine potentiates serotonergic activity through the selective inhibition of serotonin reuptake in the central nervous system. There are few reported overdoses in the literature, and of these, three were fatal. Three coroner's cases in which paroxetine was directly associated with the cause of death are reported. In case #1, paroxetine was the only drug detected in significant concentrations. The heart blood paroxetine concentration was 4.0 mg/L. Case #2 was a known suicide in which the decedent herself admitted taking pills and alcohol. The hospital blood sample drawn at admission was analyzed and contained a 0.25% ethanol level and no paroxetine. Death occurred 10 h later. The postmortem heart blood contained ethanol at 0.06%, paroxetine at 3.7 mg/L, fluoxetine at 0.86 mg/L, and norfluoxetine at 0.65 mg/L. In case #3, death was attributed to an apparent adverse drug interaction between paroxetine and imipramine/desipramine. The postmortem heart blood contained paroxetine at 1.4 mg/L, imipramine at 3.0 mg/L, and desipramine at 9.6 mg/L.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9788532     DOI: 10.1093/jat/22.6.541

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  2 in total

Review 1.  Liver and peripheral blood concentration ratio (L/P) as a marker of postmortem drug redistribution: a literature review.

Authors:  Iain M McIntyre
Journal:  Forensic Sci Med Pathol       Date:  2013-11-07       Impact factor: 2.007

2.  Paroxetine overdose.

Authors:  Arun K Gupta; Pankaj Verma; Samir K Praharaj; Dipayan Roy; Anuradha Singh
Journal:  Indian J Psychiatry       Date:  2005-07       Impact factor: 1.759

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.